Further information on these and other factors that could affect our financial results is included in the company’s Annual Report on Form 10-K for our 2020 fiscal year, which is on file with the Securities and Exchange Commission. Additional information is also set forth in the company’s quarterly reports on Form 10-Q, annual reports on Form 10-K and other filings the company makes with the Securities and Exchange Commission from time to time, copies of which may be obtained by visiting the Investor Relations portion of our web site at www.ambarella.com or the SEC's web site at www.sec.gov. Undue reliance should not be placed on the forward-looking statements in this release, which are based on information available to us on the date hereof. The results we report in our Annual Report on Form 10-K for the fiscal year ending January 31, 2021 could differ from the preliminary results announced in this press release.
Ambarella assumes no obligation and does not intend to update the forward-looking statements made in this press release, except as required by law.
Non-GAAP Financial Measures
The company has provided in this release non-GAAP financial information, including non-GAAP gross margin, net income, and earnings per share, as a supplement to the consolidated financial statements, which are prepared in accordance with generally accepted accounting principles ("GAAP"). Management uses these non-GAAP financial measures internally in analyzing the company’s financial results to assess operational performance and liquidity. The company believes that both management and investors benefit from referring to these non-GAAP financial measures in assessing its performance and when planning, forecasting and analyzing future periods. Further, the company believes these non-GAAP financial measures are useful to investors because they allow for greater transparency with respect to key financial metrics that the company uses in making operating decisions and because the company believes that investors and analysts use them to help assess the health of its business and for comparison to other companies. Non-GAAP results are presented for supplemental informational purposes only for understanding the company’s operating results. The non-GAAP information should not be considered a substitute for financial information presented in accordance with GAAP, and may be different from non-GAAP measures used by other companies.
With respect to its financial results for the fourth quarter of fiscal year 2021, the company has provided below reconciliations of its non-GAAP financial measures to its most directly comparable GAAP financial measures. With respect to the company’s expectations for the first quarter of fiscal year 2022, a reconciliation of non-GAAP gross margin and non-GAAP operating expenses guidance to the closest corresponding GAAP measure is not available without unreasonable efforts on a forward-looking basis due to the high variability and low visibility with respect to the charges excluded from these non-GAAP measures. We expect the variability of the above charges to have a significant, and potentially unpredictable, impact on our future GAAP financial results.
AMBARELLA, INC. | |||||||||||||||
CONSOLIDATED STATEMENTS OF OPERATIONS | |||||||||||||||
(in thousands, except share and per share data) | |||||||||||||||
(unaudited) | |||||||||||||||
Three Months Ended January 31, | Twelve Months Ended January 31, | ||||||||||||||
2021 | 2020 | 2021 | 2020 | ||||||||||||
Revenue | $ | 62,142 | $ | 57,212 | $ | 222,990 | $ | 228,732 | |||||||
Cost of revenue | 24,339 | 23,896 | 87,417 | 96,023 | |||||||||||
Gross profit | 37,803 | 33,316 | 135,573 | 132,709 | |||||||||||
Operating expenses: | |||||||||||||||
Research and development | 37,184 | 33,807 | 140,759 | 129,724 | |||||||||||
Selling, general and administrative | 14,632 | 13,341 | 55,980 | 52,634 | |||||||||||
Total operating expenses | 51,816 | 47,148 | 196,739 | 182,358 | |||||||||||
Loss from operations | (14,013 | ) | (13,832 | ) | (61,166 | ) | (49,649 | ) | |||||||
Other income, net | 632 | 1,713 | 3,863 | 8,021 | |||||||||||
Loss before income taxes | (13,381 | ) | (12,119 | ) | (57,303 | ) | (41,628 | ) | |||||||
Provision (benefit) for income taxes | (892 | ) | 862 | 2,483 | 3,164 | ||||||||||
Net loss | $ | (12,489 | ) | $ | (12,981 | ) | $ | (59,786 | ) | $ | (44,792 | ) | |||
Net loss per share attributable to ordinary shareholders: | |||||||||||||||
Basic | $ | (0.35 | ) | $ | (0.39 | ) | $ | (1.72 | ) | $ | (1.35 | ) | |||
Diluted | $ | (0.35 | ) | $ | (0.39 | ) | $ | (1.72 | ) | $ | (1.35 | ) | |||
Weighted-average shares used to compute net loss per share | |||||||||||||||
attributable to ordinary shareholders: | |||||||||||||||
Basic | 35,338,351 | 33,677,059 | 34,679,717 | 33,083,562 | |||||||||||
Diluted | 35,338,351 | 33,677,059 | 34,679,717 | 33,083,562 |